These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 1376923
1. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Eidelman O, Guay-Broder C, van Galen PJ, Jacobson KA, Fox C, Turner RJ, Cabantchik ZI, Pollard HB. Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5562-6. PubMed ID: 1376923 [Abstract] [Full Text] [Related]
2. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Guay-Broder C, Jacobson KA, Barnoy S, Cabantchik ZI, Guggino WB, Zeitlin PL, Turner RJ, Vergara L, Eidelman O, Pollard HB. Biochemistry; 1995 Jul 18; 34(28):9079-87. PubMed ID: 7542476 [Abstract] [Full Text] [Related]
3. Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptors. Jacobson KA, Guay-Broder C, van Galen PJ, Gallo-Rodriguez C, Melman N, Jacobson MA, Eidelman O, Pollard HB. Biochemistry; 1995 Jul 18; 34(28):9088-94. PubMed ID: 7542477 [Abstract] [Full Text] [Related]
6. CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells. Casavola V, Turner RJ, Guay-Broder C, Jacobson KA, Eidelman O, Pollard HB. Am J Physiol; 1995 Jul 18; 269(1 Pt 1):C226-33. PubMed ID: 7543243 [Abstract] [Full Text] [Related]
7. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator. Cohen BE, Lee G, Jacobson KA, Kim YC, Huang Z, Sorscher EJ, Pollard HB. Biochemistry; 1997 May 27; 36(21):6455-61. PubMed ID: 9174362 [Abstract] [Full Text] [Related]
8. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX. Andersson C, Roomans GM. Eur Respir J; 2000 May 27; 15(5):937-41. PubMed ID: 10853862 [Abstract] [Full Text] [Related]
9. Direct activation of cystic fibrosis transmembrane conductance regulator channels by 8-cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-diallyl-8-cyclohexylxanthine (DAX). Arispe N, Ma J, Jacobson KA, Pollard HB. J Biol Chem; 1998 Mar 06; 273(10):5727-34. PubMed ID: 9488705 [Abstract] [Full Text] [Related]
10. ATP and A1 adenosine receptor agonists mobilize intracellular calcium and activate K+ and Cl- currents in normal and cystic fibrosis airway epithelial cells. Rugolo M, Mastrocola T, Whörle C, Rasola A, Gruenert DC, Romeo G, Galietta LJ. J Biol Chem; 1993 Nov 25; 268(33):24779-84. PubMed ID: 8227038 [Abstract] [Full Text] [Related]
11. Long-term cAMP activation of Na(+)-K(+)-2Cl- cotransporter activity in HT-29 human adenocarcinoma cells. Slotki IN, Breuer WV, Greger R, Cabantchik ZI. Am J Physiol; 1993 Apr 25; 264(4 Pt 1):C857-65. PubMed ID: 7682775 [Abstract] [Full Text] [Related]
12. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Dray-Charier N, Paul A, Scoazec JY, Veissière D, Mergey M, Capeau J, Soubrane O, Housset C. Hepatology; 1999 Jun 25; 29(6):1624-34. PubMed ID: 10347100 [Abstract] [Full Text] [Related]
13. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Peakman MC, Hill SJ. Br J Pharmacol; 1994 Jan 25; 111(1):191-8. PubMed ID: 8012696 [Abstract] [Full Text] [Related]
14. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis. Srivastava M, Eidelman O, Pollard HB. Mol Med; 1999 Nov 25; 5(11):753-67. PubMed ID: 10656877 [Abstract] [Full Text] [Related]
15. Increasing expression of the normal human CFTR cDNA in cystic fibrosis epithelial cells results in a progressive increase in the level of CFTR protein expression, but a limit on the level of cAMP-stimulated chloride secretion. Rosenfeld MA, Rosenfeld SJ, Danel C, Banks TC, Crystal RG. Hum Gene Ther; 1994 Sep 25; 5(9):1121-9. PubMed ID: 7530494 [Abstract] [Full Text] [Related]
17. A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis. McCarty NA, Standaert TA, Teresi M, Tuthill C, Launspach J, Kelley TJ, Milgram LJ, Hilliard KA, Regelmann WE, Weatherly MR, Aitken ML, Konstan MW, Ahrens RC. Pediatr Pulmonol; 2002 Feb 15; 33(2):90-8. PubMed ID: 11802244 [Abstract] [Full Text] [Related]
18. Stimulation of chloride secretion by P1 purinoceptor agonists in cystic fibrosis phenotype airway epithelial cell line CFPEo-. Chao AC, Zifferblatt JB, Wagner JA, Dong YJ, Gruenert DC, Gardner P. Br J Pharmacol; 1994 May 15; 112(1):169-75. PubMed ID: 8032638 [Abstract] [Full Text] [Related]
19. Abnormal subcellular localization of mutated CFTR protein in a cystic fibrosis epithelial cell line. Demolombe S, Baró I, Laurent M, Hongre AS, Pavirani A, Escande D. Eur J Cell Biol; 1994 Oct 15; 65(1):214-9. PubMed ID: 7534234 [Abstract] [Full Text] [Related]
20. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Fulmer SB, Schwiebert EM, Morales MM, Guggino WB, Cutting GR. Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6832-6. PubMed ID: 7542778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]